Right ventricular outflow tract reconstruction with an allograft conduit

被引:51
作者
Gerestein, CG
Takkenberg, JJM
Oei, FBS
Cromme-Dijkhuis, AH
Spitaels, SEC
van Herwerden, LA
Steyerberg, EW
Bogers, AJJC
机构
[1] Univ Hosp Rotterdam, Dept Cardiothorac Surg, Thorax Ctr, NL-3000 WB Rotterdam, Netherlands
[2] Univ Hosp Rotterdam, Dept Cardiol, NL-3000 WB Rotterdam, Netherlands
[3] Univ Hosp Rotterdam, Dept Pediat Cardiol, NL-3000 WB Rotterdam, Netherlands
[4] Erasmus Univ, Dept Publ Hlth, Rotterdam, Netherlands
关键词
D O I
10.1016/S0003-4975(00)02440-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Allograft conduits are used for reconstruction of the right ventricular outflow tract in patients with congenital heart disease and in the pulmonary autograft procedure. A retrospective evaluation of our experience with the use of allograft conduits for reconstruction of the right ventricular outflow tract was conducted. Methods. Between August 1986 and March 1999, 316 allografts (246 pulmonary, 70 aortic) were implanted in 297 patients for reconstruction of the right ventricular outflow tract. Main diagnostic groups were aortic valve pathology (n = 112, 35%), tetralogy of Fallot (n = 71, 22%), and pulmonary atresia with ventricular septal defect (n = 46, 14%). Kaplan-Meier analyses were done for survival, valve-related reoperation, and valve-related events. In addition, Cox regression analysis was used for evaluation of potential risk factors. Results. Mean age at operation was 18 years (range, 7 days to 61 years). Mean follow-up was 4 years (range, 2 days to 12 years). Twelve patients (4%) died within 30 days after operation. Patient survival was 90% (95% confidence interval [CI], 86% to 94%) at 5 years and 88% (95% CI, 83% to 94%) at 8 years. Twenty-four reoperations were required for allograft dysfunction in 23 patients; 21 allografts were replaced. Freedom from valve-related reoperation was 91% (95% CI, 86% to 95) at 5 years and 87% (95% CI, 81% to 93%) at 8 years. Twenty-nine valve-related events were reported (2 deaths, 24 reoperations, 2 balloon dilatations, and 1 endocarditis). Freedom from valve-related events was 90% (95% CI, 85% to 94%) at 5 years after implantation, and 84% (95% CI, 77% to 91%) at 8 years. Risk factors for accelerated allograft failure were extra-anatomic position of the allograft (p 0.03; hazard ratio, 9.7) and the use of an aortic allograft (p = 0.02; hazard ratio, 2.4). Conclusions. Right ventricular outflow tract reconstruction with an allograft conduit has good medium-term results, although progression of allograft degeneration is noted. Aortic allografts should preferably not be used for reconstruction of the right ventricular outflow tract. (C) 2001 by The Society of Thoracic Surgeons.
引用
收藏
页码:911 / 917
页数:7
相关论文
共 20 条
[1]  
ALBERT JD, 1993, J THORAC CARDIOV SUR, V106, P228
[2]   OUTCOME OF PULMONARY AND AORTIC HOMOGRAFTS FOR RIGHT-VENTRICULAR OUTFLOW TRACT RECONSTRUCTION [J].
BANDO, K ;
DANIELSON, GK ;
SCHAFF, HV ;
MAIR, DD ;
JULSRUD, PR ;
PUGA, FJ .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 109 (03) :509-518
[3]  
CLEVELAND DC, 1992, CIRCULATION S2, V86, P151
[4]  
Daenen W, 1997, J HEART VALVE DIS, V6, P347
[5]  
EDMUNDS LH, 1996, J THORAC CARDIOVASC, V112, P707
[6]  
HAWKINS JA, 1992, J THORAC CARDIOV SUR, V104, P910
[7]   Immunogenic human leukocyte antigen class II antigens on human cardiac valves induce specific alloantibodies [J].
Hoekstra, FME ;
Witvliet, M ;
Knopp, CY ;
Wassenaar, C ;
Bogers, AJJC ;
Weimar, W ;
Claas, FHJ .
ANNALS OF THORACIC SURGERY, 1998, 66 (06) :2022-2026
[8]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[9]  
LIVI U, 1987, J THORAC CARDIOV SUR, V93, P755
[10]   PULMONARY HOMOGRAFT IMPLANTATION FOR VENTRICULAR OUTFLOW TRACT RECONSTRUCTION - EARLY PHASE RESULTS [J].
MCGRATH, LB ;
GONZALEZLAVIN, L ;
GRAF, D .
ANNALS OF THORACIC SURGERY, 1988, 45 (03) :273-277